News from Asia

id-100191614-1

Sosei’ subsidiary Heptares records positive outcome of Schizophrenia drug

February 12, 2016  |   News

HTL9936 is the first selective muscarinic M1 receptor agonist, designed using Heptares StaR technology

partnership-526421-640

Shire’s partner Shionogi files NDA for ADHD drug in Japan

February 12, 2016  |   News

Shire and Shionogi have been developing S-877503 as an investigational pediatric ADHD candidate

drug trail

University of Dundee, Ono Pharma to collaborate on drug research

February 11, 2016  |   News

Ono are seeking to develop a new therapy for common inflammatory diseases based on scientific discoveries made in Dundee

More News from Asia

Survey Box

Bangalore India Bio 2016

Do you want to attend Bangalore India Bio 2016 edition?

Send this article by email

X